Prostate Cancer Screening
A Matter of Routine or Patient Choice: A Discussion for Policymakers
Published 2001
This file contains a brief description of the publication and it's table of contents. To read or print the entire document, click on the following link:
 Print Version (To read portable document format (.pdf) files, you must install Adobe Acrobat Reader.)
Approx. 28 pages
This booklet provides information to increase awareness and stimulate discussion about what, if any, public health and health care policy should be enacted regarding the use of the prostate specific antigen (PSA) test to screen for prostate cancer. If you are a state or federal legislator, a national health care policy maker, a public health professional, a benefits manager or medical director of a health care plan, or someone with other health care policy decision-making influence, the information provided here may help you better understand both sides of the PSA debate.
The Association of State and Territorial Chronic Disease Program Directors (ASTCDPD) developed this booklet under a Cooperative Agreement (U58/CCU311166-03) from the U.S. Centers for Disease Control and Prevention. ASTCDPD is a voluntary, national organization of state health agency professionals who are dedicated to the prevention and control of chronic diseases. The association is an affiliate organization of the Association of State and Territorial Health Officials (ASTHO), whose members are the directors of state public health agencies. Through its standing committees and special projects, ASTCDPD works to monitor, track, and advocate for scientifically-based health care legislation and policy. Experts in prostate cancer and public health policy guided the development of this booklet.
Contents
- Making Informed Policy Choices
What is this debate about prostate screening?
What information will you find in this booklet?
What process was used to develop the discussion booklet?
- Understanding the Disease
What is the prostate?
What is the prostate specific antigen (PSA) test?
What is prostate cancer?
Disease highlights
Signs and symptoms
- Disparities in Prostate Cancer
What age group is most at risk?
Are there ethnic groups that are at higher risk?
What about a family history of prostate cancer?
What issues influence prostate screening policy?
- Using Science to Guide Decisions
What are some objective criteria for disease screening?
How is prostate cancer diagnosed?
What are the prostate cancer treatment alternatives?
Why do we screen for disease?
How do recommendations for prostate screening vary?
|
- Weighing the Costs and Benefits of Routine Screening
- Helping Men Make Appropriate Choices
Is treatment worse than the disease?
Are health care providers presenting the options?
- Looking for the Answers
Potential benefits of PSA testing
Limitations/risks of the PSA test
Complications of treatment
Has the PSA saved lives?
Recent studies
- Conclusion
- Acknowledgements
- Resources
State mandates
- Glossary
- Organizational acronyms
Words to know
- Bibliography and References
|
file posted 11/09/01
Visitor counts for this page.
|
